Articles

Kylie Jenner lists ‘modern fortress’ in swanky SoCal neighborhood for $48 million

Kylie Jenner is offloading her Los Angeles concrete megamansion for $48 million after finishing building her sprawling Hidden Hills property.

‘Sparkle, color, and glitter’: See how Jonathan Scott and Zooey Deschanel decorated their $9.5 million L.A. home for the holidays

“Property Brothers” star Jonathan Scott and actress Zooey Deschanel, who got engaged in 2023, have decked the halls of their sprawling Los Angeles home.

Meta acquisition is latest megacap tech bet on AI to finish the year

Giant tech companies are closing the year with a flurry of deals as they position for further advances in artificial intelligence.

Strategy’s stock falls to fresh lows after using more share sales to buy bitcoin

The company’s shares fell to a 15-month low amid a decline in bitcoin prices and another dilutive share sale.

Beyoncé just became a billionaire. Here’s how she did it.

Beyoncé is just the fifth musical artist to achieve billionaire status.

Trump eyes January for announcement of Powell replacement as he renews attacks on Fed chief

President Donald Trump on Monday revived his threat to sue over Federal Reserve building renovations.

The Fed has gone into hibernation. Tuesday may bring clues to how long it might wait to emerge.

Federal Reserve officials are clearly divided about whether higher inflation or a weaker economy is the bigger risk going forward.

This winning fund manager spills 4 secrets about smart ways to buy non-U.S. stocks

David Herro is an experienced guide to the global market.

Why your kitchen cabinets and furniture could get more expensive next year

Prices for some everyday home items may be about to get more expensive, as U.S. tariff rates on imports of certain furniture and kitchen cabinets are set to rise beginning Thursday.

‘The bulls are definitely spooked’: Has silver’s stunning rise this year run out of steam?

Thin holiday trading, higher margin costs and other factors trigger silver’s biggest daily dollar decline since 1980.

The miracle of curing Alzheimer’s? No longer an impossibility.

More research shows the disease may one day be reversible.

These biotech stocks are getting hammered by shocking brittle-bone treatment study results

Shares of both Ultragenyx and Mereo BioPharma were seeing record selloffs after disappointing trial results for setrusumab.
1 3 4 5 6 7 2,509